Working… Menu
Trial record 5 of 5 for:    ATYR1940

Evaluate Safety and Biological Activity of ATYR1940 in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy (FSHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02603562
Recruitment Status : Completed
First Posted : November 13, 2015
Last Update Posted : May 17, 2017
Information provided by (Responsible Party):
aTyr Pharma, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 13, 2016
Actual Study Completion Date : February 14, 2017